KRYSTAL BIOTECH INC (KRYS:NASDAQ)
$332.29 7.74 (2.3848%)
Analysed KRYSTAL BIOTECH INC (KRYS:NASDAQ) News Sources
Krystal Biotech (KRYS) Has a Blockbuster Rare-Disease Drug. Is Its Moat Durable?
06-10-2026
yahoo.com
Krystal Biotech (KRYS) Stock Looks Overvalued After A 7x Run
08-10-2026
yahoo.com
Why Krystal Biotech (KRYS) Is Drawing Fresh Attention
08-10-2026
yahoo.com
What Krystal Biotech (KRYS)'s VYJUVEK Gene Therapy Momentum Means For Shareholders
08-10-2026
yahoo.com
Krystal Biotech Announces Positive Clinical Data for New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression in Patients with Gorlin Syndrome
15-10-2026
yahoo.com
Krystal Biotech Reports KB113 Lesion Regression in Gorlin Syndrome Pilot Study as FDA Discussions Begin
15-10-2026
advfn.com
Cystic Fibrosis Market Poised for Growth During the Forecast Period (2026-2036) as CFTR Modulators Transform Treatment Landscape | DelveInsight
21-10-2026
yahoo.com
Krystal Biotech to Report Third Quarter 2026 Financial Results on November 2, 2026
22-10-2026
yahoo.com
Analysts Estimate Krystal Biotech, Inc. (KRYS) to Report a Decline in Earnings: What to Look Out for
26-10-2026
yahoo.com
Has The Story Under Krystal Biotech Stock Run Out?
28-10-2026
trefis.com
What is the current price of KRYSTAL BIOTECH INC (KRYS:NASDAQ)?
The current price of KRYSTAL BIOTECH INC (KRYS:NASDAQ) is $332.29.
KRYSTAL BIOTECH INC (KRYS:NASDAQ) absolute price change since previous trading day?
The absolute price change of KRYSTAL BIOTECH INC (KRYS:NASDAQ) since the previous trading day is $7.74.
KRYSTAL BIOTECH INC (KRYS:NASDAQ) percentage price change since previous trading day?
The percentage price change of KRYSTAL BIOTECH INC (KRYS:NASDAQ) since the previous trading day is 2.3848%.
What is the most recent average sentiment score for KRYSTAL BIOTECH INC (KRYS:NASDAQ)?
The most recent average sentiment score for KRYSTAL BIOTECH INC (KRYS:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for KRYSTAL BIOTECH INC (KRYS:NASDAQ)?
The most recent sentiment for KRYSTAL BIOTECH INC (KRYS:NASDAQ) is .
SEC-8K** Filing Available For KRYSTAL BIOTECH INC (KRYS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.